L35.Treatment of Thrombosis: Heparin Anticoagulants I Flashcards
Heparin-MOA
- complex with ATIII and induces a conformational change resulting in 1000x greater binding affinity to clotting factor proteases
- [it can then leave and do the same with another AT3]
- indirect effect on thrombin, acts like a catalyst in an enzymatic rxn.
- also inhibits factors 10a and 2a.
- monitored by APTT (2-2.5 baseline therapeutic).
Heparin-Route of Admin
- mainly iv and also given subcutaneous (NOT absorbed via oral or rectal route).
- usually given as an iv bolus followed by an iv infusion, monitored daily to keep in range
Heparin-Indications
surgical anticoagulation
Heparin-Adverse Effects
- **hemorrhagic complications (bleeding); adrenal, gut, etc
- HIT** (heparin induced thrombocytopenia) and HiThrombosis
- ->generation of ANTI-hep/PF4 complex antibodies
- ->Ab bind to & activate platelets and endothelial cells (can lead to loss of limbs!!)
- osteoporosis-manifestation with spontaneous fracture following chronic admin and large doses
- alopecia-from LT usage
LMW Heparins (B&G)-MOA
complex with AT and inhibits factors 10a and 2a. monitored by anti-10a.
LMW Heparins (B&G)-Route of Admin
subcutaneous
LMW Heparins (B&G)-Indications
prophylaxis and treatment of DVT and ACS
LMW Heparins (B&G)-Adverse Effects
bleeding
Fondaparinux (pentasaccharide)-MOA
complex with AT and inhibits factor 10a
Fondaparinux-Route of Admin
subcutaneous
Fondaparinux-Indications
management of DVT
Fondaparinux-Adverse Effects
bleeding
Argatroban-MOA
directly inhibits 2a
Argatroban-Route of Admin
intravenous
Argatroban-Indications
anticoagulant management of HIT patients
Argatroban-Adverse Effects
bleeding
Bivalirudin-MOA
directly inhibits 2a
Bivalirudin-Route of Administration
intravenous
Bivalirudin-Indications
anticoagulant management of HIT patients
Bivalirudin-Adverse Effects
bleeding
Hirudin-MOA
directly inhibits 2a
Hirudin-Route of Admin
intravenous
Hirudin-Indications
anticoagulant management of HIT patients
Hirudin-Adverse Effects
bleeding
Antithrombin Concentrate-MOA
directly inhibits 2a
Antithrombin Concentrate-Route of Admin
intravenous